Supernus Pharmaceuticals reported $91.54M in Stock for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Ani Pharmaceuticals ANIP:US USD 105.35M 9.46M
Aurora Cannabis Inc ACB:CN CAD 122.59M 23.65M
Canopy Growth Corp WEED:CN CAD 213.94M 2.73M
Cara Therapeutics CARA:US USD 2.38M 548K
Corcept Therapeutics CORT:US USD 6.1M 10.97M
Eisai 4523:JP JPY 120.86B 6.45B
Endo International Ordinary Shares ENDP:US USD 288.91M 1.16M
Horizon Pharma HZNP:US USD 169.56M 20.7M
Lannett LCI:US USD 94.78M 658K
Marinus Pharmaceuticals MRNS:US USD 77K 27K
Pacira Pharmaceuticals PCRX:US USD 96.06M 736K
Perrigo Ordinary Shares PRGO:US USD 1.15B 65.1M
Revance Therapeutics RVNC:US USD 18.32M 1.15M
Supernus Pharmaceuticals SUPN:US USD 91.54M 8.38M
Teva Pharmaceutical Industries TEVA:US USD 3.83B 26M
United Therapeutics UTHR:US USD 102M 11M
Xeris Pharmaceuticals Inc XERS:US USD 24.74M 4.61M